IPO
BioArctic AB to publish the company’s Interim Report for the period January – March 2019 on Thursday, May 9, 2019 at 08:00 a.m. CET.
Motif Bio plc announced that its notice of its Annual General Meeting have been posted to shareholders and will shortly be available for download from the Company’s website at www.motifbio.com.
Karolinska Development AB announces that The Board of Directors has decided to delay the publication of its Annual Report for 2018.
Galapagos NV presents financial results and highlights the key events for the first quarter of 2019.
Conference call to be held today, 25 April 2019, 3:00pm CET/2:00pm BST
Preparations for Upcoming Clinical Data in the MERECA and GIST Studies and First Patient Treated in the ILIAD Study
Assertio Therapeutics, Inc. announced that it will release first quarter 2019 financial results on Wednesday, May 8, 2019, after the close of markets.
Pharnext SA announced its financial results for the fiscal year ended December 31st, 2018.
MDxHealth SA, a commercial-stage innovative molecular diagnostics company, provided a business update for the first quarter ended March 31, 2019.
Retrophin, Inc. announced it will report first quarter 2019 financial results on Tuesday, May 7, 2019 after the close of the U.S. financial markets.
PRESS RELEASES